Tuesday's #PreMarket Movers: Neuroderm, Microsoft, Medbox, Civeo And More

Neuroderm Ltd (NASDAQ: NDRM) +30% - The company announced favorable Phase IIa Parkinson’s treatment study results.

China Jo-Jo Drugstores Inc (NASDAQ: CJJD) +9% - Shares are higher following a report of potential legalization of online prescription drugs sales in China.

XenoPort, Inc. (NASDAQ: XNPT) +9% - Late Monday, RBC analyst Michael Yee said XenoPort is his “under the radar play for 2015.”

Kandi Technologies Group Inc (NASDAQ: KNDI) +4.3% - The rise in share price is a result of the announcement that China will extend green vehicle subsidies until 2020.

Cnova NV (NASDAQ: CNV) +3% - Shares were initiated with an Overweight rating at JPMorgan and Morgan Stanleyand a Buy rating at Bank of America.

Idera Pharmaceuticals Inc (NASDAQ: IDRA) +1.8% - The company received FDA orphan drug designation for IMO-8400.

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) +1% - Ariad announced a commercialization deal for Iclusig in seven countries.

Microsoft Corporation (NASDAQ: MSFT) +0.11% - Microsoft named “top pick” at Piper Jaffray for 2015.

Civeo Corp (NYSE: CVEO) -35% - After hours Monday, the company announced Q1 guidance below estimates and suspended its quarterly dividend.

Medbox Inc (OTC: MDBX) -16% - The company announced it will amend prior period financial results.

Procter & Gamble Co (NYSE: PG) -1% - Shares were downgraded to Neutral at BTIG.